| abstract |
Disclosed are N-heterocyclic compounds that block cytokine production by inhibiting p38 kinase. In one embodiment, the compounds of the present invention have formula I: Embedded image It is represented by Also disclosed are methods of manufacture, pharmaceutical compositions, and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-α expression using the compounds of the present invention. |